Company: NKLR
Filing Date: 2025-11-10
Form Type: S-1
Source: 0001213900-25-108246
Chunk: 295

Company: Terra Innovatum Global N.V.
Filing Date: 2025-11-10
Form: S-1
Chunk 295
---
 cash fees:

| ● | $150,000, that was paid immediately upon the close of the business combination; |

| ● | $125,000, payable 90 days after the close; |

| ● | $125,000, payable 180 days after the close. |

<div align='center'>F-67

Terra Innovatum Global, Srl.
Notes to the Consolidated Financial Statements
(Unaudited)</div>

Note 14. Subsequent Events(cont.)

These fees are in consideration of B. Riley’s
services, which include advising on the business combination, capital markets strategy, and other customary investment banking services.

The agreement also includes standard indemnification
provisions and limitations of liability, and provides for additional compensation of $2,000 per person, per day, plus expenses, if B.
Riley personnel are required to testify in any proceedings related to the engagement.

Business Combination and Public Listing

In October 2025, Terra Innovatum Global N.V. consummated
the Merger, pursuant to the Business Combination Agreement dated April 21, 2025. As part of the transaction, Terra Innovatum Global Srl.
converted into a Dutch public limited liability company, Terra Innovatum Global N.V.

Following the Merger, GSR III merged with and into
GSR III Cayman Merger Sub, a wholly owned subsidiary, with GSR III surviving as a wholly owned subsidiary of Terra Innovatum Global N.V.
whose ordinary shares commenced trading on The Nasdaq Stock Market LLC under the ticker symbol “NKLR” on October 10, 2025.

In connection with the Merger, Terra Innovatum Global N.V.:

| ● | Issued 70,300,948 ordinary shares. |

| ● | Received PIPE proceeds totaling $36,790,000, pursuant to subscription agreements, consisting of the issuance of 3,683,500 PIPE shares,        
 half warrants to purchase up to 1,841,750 ordinary shares at an exercise price of $12.00 per share, and quarter warrants to purchase up       
 to 920,875 ordinary shares at an exercise price of $16.00 per share. Additionally, converted $5,690,000 in bridge loans into 851,483 ordinary 
 shares at a conversion price of $7.00 per share.                                                                                              |

| ● | Issued bridge warrants to purchase 851,483 ordinary shares at $11.50 per share and 851,483 ordinary shares at $15.